Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Levitan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 21, 2003
Combination chemotherapy with topotecan for non-small cell lung cancerAfshin Dowlati, Nathan Levitan
Academic Medicine : Journal of the Association of American Medical Colleges|May 26, 2007
Program report cards: evaluation across multiple residency programs at one institutionRoy Phitayakorn, Nathan Levitan, Jerry M Shuck
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 1, 2021
Quality and cost outcomes of an integrated supportive care programElizabeth Weinstein, Matthew Kemmann, Sara L Douglas, et al.
Clinical Lung Cancer|August 18, 2004
Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology GroupChandra P Belani, Sudeshna Adak, Seena Aisner, et al.
Gastrointestinal Endoscopy|April 30, 2002
Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinomaJoseph Willis, Gregory S Cooper, Gerard Isenberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2009
A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology GroupLeora Horn, Patricia Bernardo, Alan Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trialFrancis W Nugent, Wilson C Mertens, Stephen Graziano, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2007
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapyAfshin Dowlati, Shanmuga Subbiah, Matthew Cooney, et al.
Investigational New Drugs|July 22, 2005
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancerAfshin Dowlati, Robert Chapman, Shanmuga Subbiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyFrances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|October 21, 2003
Combination chemotherapy with topotecan for non-small cell lung cancerAfshin Dowlati, Nathan Levitan
Academic Medicine : Journal of the Association of American Medical Colleges|May 26, 2007
Program report cards: evaluation across multiple residency programs at one institutionRoy Phitayakorn, Nathan Levitan, Jerry M Shuck
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 1, 2021
Quality and cost outcomes of an integrated supportive care programElizabeth Weinstein, Matthew Kemmann, Sara L Douglas, et al.
Clinical Lung Cancer|August 18, 2004
Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology GroupChandra P Belani, Sudeshna Adak, Seena Aisner, et al.
Gastrointestinal Endoscopy|April 30, 2002
Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinomaJoseph Willis, Gregory S Cooper, Gerard Isenberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2009
A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology GroupLeora Horn, Patricia Bernardo, Alan Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trialFrancis W Nugent, Wilson C Mertens, Stephen Graziano, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2007
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapyAfshin Dowlati, Shanmuga Subbiah, Matthew Cooney, et al.
Investigational New Drugs|July 22, 2005
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancerAfshin Dowlati, Robert Chapman, Shanmuga Subbiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyFrances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.
Pageof 2